Peramivir

DB06614ApprovedInvestigationalSmall moleculeNeuraminidase Inhibitors

Peramivir is an intravenous antiviral agent used to treat acute uncomplicated influenza in patients aged 2 years and older who are shown to be symptomatic for no more than two days. The development of peramivir has been supported by the US Department of Health and Human Services as part of the government's effort to prepare for a flu pandemic.

Chemical structure of Peramivir
Mechanism
Curator reviewed
Primary indication
Peramivir is indicated for the treatment of acute uncomplicated influenza in patients six months and older who have been symptomatic for no more than two days.Curator reviewed · 1 structured indication
Formula / weight
C15H28N4O4 · 328.4072 g/mol (avg)
First approval
Canada, 2018 · United States, 2014
Code names
RWJ-270201
Brand names
  • Rapivab

Resolves to

Compound
UNII9ZS94HQO3BCAS330600-85-6ChEMBLCHEMBL139367ChEBI85202PubChem154234
Clinical / RWD
RxNorm619693ATCJ05AH03
Structure
InChIKeyXRQDFNLINLXZLB-CKIKVBCHSA-NSMILES[H][C@@]1([C@@H](NC(C)=O)C(CC)CC)[C@H](O)[C@H](C[C@H]1NC(N)=N)C(O)=O
Targets
P03472NAP03474NAP06818NAP27907NA

What you can answer from here — as of September 12, 2026

4Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
18Drug interactionsStructured to mechanism, not free text
Sign in
14Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1Structured indicationCondition, population, route and combination as fields, not prose
Sign in
8Marketed productsAcross 5 countries and 5 labellers
Sign in
1ATC codeIncluding every combination product, plus 10 drug categories
Sign in
9+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Peramivir, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In